Axsome Therapeutics (AXSM) Gains from Investment Securities (2015 - 2018)
Axsome Therapeutics (AXSM) reported Gains from Investment Securities of -$102000.0 for Q4 2018, down 580.0% sequentially from -$15000.0 in Q3 2018.
Axsome Therapeutics (AXSM) Gains from Investment Securities (2015 - 2018) Analysis & Trends
Axsome Therapeutics (AXSM) has 2 years of Gains from Investment Securities data on file, last reported at -$102000.0 in Q4 2018.
- For the quarter ending Q4 2018, Gains from Investment Securities changed N/A year-over-year to -$102000.0; the trailing twelve-month figure through Dec 2018 stood at -$2.8 million (changed N/A YoY), and the FY2018 full-year result was -$2.8 million, down 532.04% from the prior year.
- Gains from Investment Securities declined to -$102000.0 in Q4 2018, from -$15000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $93976.0 in Q4 2015 to a low of -$2.7 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Axsome Therapeutics | 12.28 Bn | 11.98 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -102,000.00 |
| Dec 31, 2018 | -102,000.00 |
| Sep 30, 2018 | -15,000.00 |
| Sep 30, 2018 | -15,000.00 |
| Jun 30, 2018 | -1,000.00 |
| Jun 30, 2018 | -1,000.00 |
| Mar 31, 2018 | -2.67 Mn |
| Mar 31, 2018 | -2.67 Mn |
| Dec 31, 2015 | 93,976.00 |
| Dec 31, 2015 | 93,976.00 |
| Sep 30, 2015 | 32,005.00 |
| Sep 30, 2015 | 32,005.00 |
| Jun 30, 2015 | -16,572.00 |
| Jun 30, 2015 | -16,572.00 |
| Mar 31, 2015 | -870.00 |
| Mar 31, 2015 | -870.00 |